drugset / Trial / NCT01893281

The Effect of Testosterone Topical Solution (LY900011) in Hypogonadal Men With Suboptimal Response to a Topical Testosterone Gel

NCT01893281

Phase 4 Completed 78 enrolled Eli Lilly and Company
NaSingle-groupOpen-labelTreatment

Summary

This study will evaluate if testosterone solution can raise testosterone hormone levels into the normal range after treatment for up to 9 Weeks, in those participants with a documented history of subtherapeutic levels \[total testosterone \<300 nanograms per deciliter (ng/dL)\] when previously treated with a topical testosterone gel.

Timeline

Start
2013-07
Primary completion
2014-01
Completion
2014-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Testosterone Small molecule 30 mg Topical
Subject Testosterone Small molecule 120 mg Topical

Indications